SET and neoplasm: Oncoproteins such as cancerous inhibitors of PP2A and SET can inhibit the tumor suppressive effects of the PP2A-B56 complex, whereas cAMP-regulated phosphoprotein 19 interferes with the protective activity of the PP2A-B55 enzyme 61, 66, 67.